Complete Natal Dha

Complete Natal Dha

Complete Natal Dha Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Since daily ingestion of more than 3 grams per day of omega-3 fatty acids [including alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA)] from fish oilsmay have potential antithrombotic activities and may increase bleeding times, administration of DHA should be avoided in patients with inherited or acquired bleeding, diatheses, including those taking anticoagulants.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Uses

There is currently no usage information available for this product. We apologize for any inconvenience.

History

There is currently no drug history available for this drug.

Other Information

There are no additional details available for this product.

Complete Natal Dha Manufacturers


  • Trigen Laboratories, Inc.
    Complete Natal Dha (.beta.-carotene, Ascorbic Acid, Cholecalciferol, .alpha.-tocopheryo Acetate, Dl, Thiamine Mononitrate, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Magnesium Oxide, Zinc Oxide, Cupric Oxide, And Doconexent) Kit [Trigen Laboratories, Inc.]

Login To Your Free Account